News

Genus Oncology has also filed an investigational new drug (IND) application with the US Food & Drug Administration (FDA). The prospective, open-label Phase I trial is designed to

Veeva Vault will deliver on the promise of deploying a flexible content management system across the entire company, spanning promotional materials management, R&D submissions, quality and manufacturing, and

The NG Class represents a new detergent family based on the maltose-neopentyl amphiphile design, and is more capable than current leading detergents, such as n-dodecyl-ß-D-maltoside (DDM) in speeding

In addition, Panmure Gordon has conditionally placed £3.4 million of existing shares on behalf of certain selling shareholders. e-Therapeutics is developing its own drug development pipeline, which includes

Fosmidomycin is a molecule that possesses antimalarial and antibacterial activity. The co-development project follows reports of the emergence of artemisinin resistance on the Thai-Cambodian border. Jomaa Pharma MD

Thestherapeutics include RNAi-, microRNA- and antisense-based drugs. Marina Biotech recently entered into a partnership with Debiopharm to fully fund the development of its bladder cancer program using its

ADI is a microbial enzyme, arginine deiminase that degrades the amino acid arginine. ADI-PEG 20 is ADI conjugated with polyethylene glycol (PEG), and can selectively kill cancer cells

The NurOwn technology processes adult human mesenchymal stem cells present in bone marrow which can self-renew and differentiate into many other cell types. The orphan status entitles BrainStorm

Oligonol is a proprietary form of lychee fruit extract which shows improved bioavailability due to its low-molecular weight polyphenols. The study measured the effects of Oligonol intake on